Evicenter
MarkdownMedical informationP&T meetings
Psilocybin (COMP360)

Treatment-resistant depression

Manufacturer
COMPASS Pathways
Last updated
261 sources

Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care

Repetitive transcranial magnetic stimulation

10 evidence topics · 10 sources

CANMAT guideline: rTMS and theta burst protocols

“Repetitive TMS shows efficacy for DTD, with response rates of 40% to 50%” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“High-frequency (5 Hz or higher) rTMS delivered over the left dorsolateral prefrontal cortex (DLPFC) has the largest evidence base and is recommended as a first-line protocol, along with low-frequency (1 Hz or lower) rTMS delivered over the right DLPFC.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“TBS is recommended as a first-line protocol” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“Accelerated iTBS to the left DLPFC has evidence for efficacy and a large RCT found no significant differences between accelerated bilateral TBS and high frequency rTMS.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“Unlike ECT, rTMS does not require anaesthesia and has no cognitive side effects.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“Finally, except in emergent situations as mentioned above, rTMS should generally be considered before ECT, given its less invasive nature and that individuals may continue to work or attend school while undergoing rTMS.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote